Completed NA INTERVENTIONAL 2-arm NCT05359666

Retrospective Independent Safety Review of Closed Irrisept Study

An Independent Review of Safety Data From a Closed Clinical Study Using Irrisept (Protocol IRR-CT-901-2013-01)

Sponsor: Irrimax Corporation

Updated 5 times since 2022 Last updated: Jul 20, 2023 Started: Mar 31, 2020 Primary completion: Nov 29, 2021 Completion: Nov 29, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Adverse Events, this trial is completed. The trial is conducted by Irrimax Corporation and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2023 — Jul 2024 [monthly]

Completed NA
Jun 2022 — Sep 2023 [monthly]

Completed NA

First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Irrimax Corporation

Data source: Irrimax Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Baltimore, United States , Cincinnati, United States , Cleveland, United States , Dallas, United States , Denver, United States , Houston, United States , Iowa City, United States , Lexington, United States , Los Angeles, United States , Memphis, United States and 7 more locations